We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
+3.24%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
AUM
$137M
AUM Growth
+$8.91M
Cap. Flow
+$5.42M
Cap. Flow %
3.95%
Top 10 Hldgs %
25.75%
Holding
1,127
New
41
Increased
160
Reduced
183
Closed
74

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$2.38M
2
BEAT
BioTelemetry, Inc.
BEAT
+$1.32M
3
RPM icon
RPM International
RPM
+$798K
4
DIS icon
Walt Disney
DIS
+$758K
5
COST icon
Costco
COST
+$641K

Sector Composition

Rank Sector Weight
1 Technology 27.32%
2 Healthcare 15.28%
3 Financials 10.67%
4 Consumer Staples 7.75%
5 Consumer Discretionary 5.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SFL icon
526
SFL Corp
SFL
$1.59B
$6K ﹤0.01%
500
SSNC icon
527
SS&C Technologies
SSNC
$17.8B
$6K ﹤0.01%
101
STLA icon
528
Stellantis
STLA
$16.5B
$6K ﹤0.01%
451
+6
+1% +$87
TNDM icon
529
Tandem Diabetes Care
TNDM
$1.17B
$6K ﹤0.01%
100
TRI icon
530
Thomson Reuters
TRI
$39.4B
$6K ﹤0.01%
95
-1
-1% -$66
UNP icon
531
Union Pacific
UNP
$182B
$6K ﹤0.01%
38
+2
+6% +$343
WST icon
532
West Pharmaceutical
WST
$23.1B
$6K ﹤0.01%
50
STI
533
DELISTED
SunTrust Banks, Inc.
STI
$6K ﹤0.01%
91
+26
+40% +$1.63K
AXA
534
DELISTED
AXA ADS (1 ORD SHS)
AXA
$6K ﹤0.01%
235
-492
-68% -$12.6K
AER icon
535
AerCap
AER
$23.9B
$5K ﹤0.01%
92
AMCR icon
536
Amcor
AMCR
$20.6B
$5K ﹤0.01%
+79
New +$4.38K
AVY icon
537
Avery Dennison
AVY
$12.3B
$5K ﹤0.01%
44
BIO icon
538
Bio-Rad Laboratories Class A
BIO
$8.42B
$5K ﹤0.01%
15
BSBR icon
539
Santander
BSBR
$39.7B
$5K ﹤0.01%
425
-84
-17% -$913
CGNX icon
540
Cognex
CGNX
$10.3B
$5K ﹤0.01%
95
CRI icon
541
Carter's
CRI
$1.43B
$5K ﹤0.01%
50
DGRS icon
542
WisdomTree Trust WisdomTree US SmallCap Quality Dividend Growth Fund
DGRS
$401M
$5K ﹤0.01%
132
DJP icon
543
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$819M
$5K ﹤0.01%
242
-199
-45% -$4.43K
EFV icon
544
iShares MSCI EAFE Value ETF
EFV
$27.6B
$5K ﹤0.01%
110
FL
545
DELISTED
Foot Locker
FL
$5K ﹤0.01%
113
HMC icon
546
Honda
HMC
$36.5B
$5K ﹤0.01%
199
-104
-34% -$2.77K
IART icon
547
Integra LifeSciences
IART
$1.54B
$5K ﹤0.01%
84
IQV icon
548
IQVIA
IQV
$34.7B
$5K ﹤0.01%
31
IWM icon
549
iShares Russell 2000 ETF
IWM
$80.9B
$5K ﹤0.01%
35
JAZZ icon
550
Jazz Pharmaceuticals
JAZZ
$15.9B
$5K ﹤0.01%
32

Similar funds

Front Row Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Front Row Advisors held 1,127 positions worth $137M, up 6.9% from $128M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Front Row Advisors deployed $5.42M of net new capital in Q2 2019, opening 41 new positions and adding to 160 existing holdings. Its largest new stake was BioTelemetry, Inc.: 25,089 shares worth $1.21M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Microsoft, an estimated $206K trimmed.

  • Front Row Advisors's largest Q2 2019 buy was BioTelemetry, Inc.: 25,089 shares worth $1.21M.
  • Front Row Advisors added most to Medtronic in Q2 2019, an estimated $2.38M increase.
  • Front Row Advisors's biggest Q2 2019 reduction was Microsoft, cutting an estimated $206K.
  • Front Row Advisors fully exited iRobot in Q2 2019, selling an estimated $1.7M.
  • Front Row Advisors's ten largest holdings make up 26% of its $137M portfolio in Q2 2019.
  • Front Row Advisors opened 41 new positions and closed 74 in Q2 2019.
  • Front Row Advisors's portfolio value rose 6.9% quarter-over-quarter to $137M.

Based on Front Row Advisors's 13F filing for Q2 2019, filed 27 Aug 2019.